Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-29

FDA Approved: TERIFLUNOMIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for teriflunomide by Glenmark Pharmaceuticals Inc., USA. Teriflunomide is a disease-modifying therapy indicated for rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)